# EDGAR Filing Document

**Accession Number:** 0001605888
**File Stem:** 0001213900-26-014260
**Filing Date:** 2026-2
**Character Count:** 88197
**Document Hash:** fc86662be664fa3439a89b3ca86508a5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-014260.hdr.sgml**: 20260210

**ACCESSION NUMBER**: 0001213900-26-014260

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20260210

**DATE AS OF CHANGE**: 20260210

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ATLANTIC INTERNATIONAL CORP.
- **CENTRAL INDEX KEY:** 0001605888
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 465319744
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94545
- **FILM NUMBER:** 26615916

**BUSINESS ADDRESS:**
- **STREET 1:** 270 SYLVAN AVENUE
- **STREET 2:** SUITE 2230
- **CITY:** ENGLEWOOD CLIFFS
- **STATE:** NJ
- **ZIP:** 07632
- **BUSINESS PHONE:** 2018994470

**MAIL ADDRESS:**
- **STREET 1:** 270 SYLVAN AVENUE
- **STREET 2:** SUITE 2230
- **CITY:** ENGLEWOOD CLIFFS
- **STATE:** NJ
- **ZIP:** 07632

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SeqLL, Inc.
- **DATE OF NAME CHANGE:** 20140417
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Franke Guus Paul Wilhelm
- **CENTRAL INDEX KEY:** 0002109214

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** GUBELSTRASSE 11
- **STREET 2:** CH-6300
- **CITY:** ZUG
- **PROVINCE COUNTRY:** V8
- **ZIP:** 00000

## Exhibit 99.4

**Exhibit 99.4**

**VOTING AND SUPPORT AGREEMENT**

This VOTING AND SUPPORT AGREEMENT (this "<u>Agreement</u>"), is dated as of January [●], 2026 (the "<u>Effective Date</u>"), is made by and among Axiom Partners GmbH, a company organized under the laws of the Swiss Republic ("<u>Axiom</u>"), Atlantic International Corp., a Delaware corporation ("<u>Company</u>"), and each of the stockholders of the Company as set forth on <u>Exhibit A</u> attached hereto (collectively, the "<u>Stockholders</u>," and individually a "<u>Stockholder</u>"). Axiom, Company and the Stockholders are referred to herein individually as a "<u>Party</u>" and collectively as the "<u>Parties</u>." Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Acquisition Agreement (as defined below).

**RECITALS**

WHEREAS, concurrently with the execution and delivery of this Agreement, Axiom, Atlantic and Circle8 B.V., a company organized under the laws of the Netherlands ("<u>Circle8</u>"), are entering into an Acquisition Agreement, dated as of the date hereof (the "<u>Acquisition Agreement</u>"), pursuant to which, among other things and subject to the terms and conditions of the Acquisition Agreement, Company will acquire Circle8 (the "<u>Acquisition</u>") in exchange for the issuance at Closing of shares representing 19.99% of the issued and outstanding common stock of Atlantic and the Convertible Note;

WHEREAS, the board of directors of Atlantic (the "<u>Atlantic Board</u>") has (a) determined that the Acquisition Agreement and all ancillary documents to which Atlantic is or will be a party and the transactions contemplated thereby, including the Acquisition and the Conversion, are fair to and in the best interests of Atlantic and its stockholders, (b) approved, adopted and declared advisable the Acquisition Agreement and the transactions contemplated thereby, including the Acquisition, in accordance with the requirements of the DGCL and (c) resolved to recommend approval of (i) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (ii) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that the Convertible Promissory Note issued to IDC Technologies, Inc. (as assigned) (the "<u>IDC Note</u>") converts, and (iii) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto (such approval, the "<u>Requisite Approval</u>");

WHEREAS, as of the Effective Date, each Stockholder is the record and beneficial owner of the number of shares of Company Common Stock set forth opposite such Stockholder's name on <u>Exhibit A</u> attached hereto (each, including any such Additional Securities (as defined below) an "<u>Owned Share</u>"); and

WHEREAS, as a condition and an inducement to the willingness of Axiom and Circle8 to enter into the Acquisition Agreement, concurrently with the execution and delivery of the Acquisition Agreement, the Stockholders are entering into this Agreement with Axiom and Company, pursuant to which, among other things, each such Stockholder has agreed to vote as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

**ARTICLE I<br> STOCKHOLDERS CONSENT;<br> AGREEMENT TO VOTE AND IRREVOCABLE PROXY**

**Section 1.1 Agreement to Vote**

Each Stockholder hereby irrevocably and unconditionally agrees that, from the Effective Date until the earlier of (a) the time that the Requisite Approval has been obtained and (b) termination of this Agreement in accordance with <u>Section 4.1</u> (the "<u>Agreement Term</u>"), such Stockholder shall (i) take all such actions as may be reasonably required to cause each of such Stockholder's Owned Shares to be present, in person or by proxy, at the Company Stockholder Meeting and (ii) at any Company Stockholder Meeting vote (or cause to be voted), to the extent entitled to vote thereon, all of such Stockholder's Owned Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) in favor of (I) approval of (1) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (2) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that IDC Note converts, and (3) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto, and (II) the approval of any proposal to adjourn such Company Stockholder Meeting to a later date if there are not sufficient votes for approval of (1) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (2) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that IDC Note converts, and (3) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) against (I) any Alternative Proposal, (II) any action that would reasonably be expected to result in a breach of or failure to perform any representation, warranty, covenant or agreement of the Company under the Acquisition Agreement or the Convertible Note or of such Stockholder under this Agreement, (III) any action that would reasonably be expected to prevent or materially delay or impede the consummation of the transactions contemplated by the Acquisition Agreement, including the Conversion and the issuance of any Contingent Share Consideration, (IV) any merger agreement or merger (other than the Acquisition Agreement and the Conversion), consolidation, combination, material business transaction, sale of assets, reorganization, recapitalization, dissolution, liquidation or winding up of the Company or any of its Subsidiaries, and (V) any amendment of the Company's organizational documents that would reasonably be expected to impair the ability of the Company, Axiom or Circle8 to complete the Contemplated Transactions (including the Conversion and the issuance of any contingent Share Consideration), or that would or would reasonably be expected to prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the consummation of the Conversion or the issuance of the Contingent Share Consideration.

**Section 1.2 Other Voting Rights**

For the avoidance of doubt, except as expressly set forth in this Agreement, nothing in this Agreement shall limit the right of any Stockholder to vote in favor of, against, or abstain with respect to any matter presented to the Company's stockholders not addressed by this Agreement.

**Section 1.3 Grant of Irrevocable Proxy**

Each Stockholder hereby irrevocably appoints Company and any designee of Company, and each of them individually, as such Stockholder's proxy and attorney-in-fact, with full power of substitution and resubstitution, to vote at the Company Stockholder Meeting during the Agreement Term, with respect to such Stockholder's Owned Shares as of the applicable record date, in each case solely to the extent and in the manner specified in <u>Section 1.1</u> (the "<u>Proxy</u>"); <u>provided</u>, <u>however</u>, that such Proxy shall be effective if, and only if, the Stockholder has not delivered to the Corporate Secretary of the Company, at least two Business Days prior to the Company Stockholder Meeting, a duly executed proxy card directing that such Stockholder's Owned Shares be voted in accordance with <u>Section 1.1</u>. The Proxy is given to secure the performance of the duties of each Stockholder under this Agreement, and its existence will not be deemed to relieve any Stockholder of such Stockholder's obligations under this Agreement. The Proxy shall expire and be deemed revoked automatically at the expiration of the Agreement Term or in the event of termination of this Agreement pursuant to <u>Section 4.1</u>.

**Section 1.4 Nature of Irrevocable Proxy**

The Proxy granted by each Stockholder is irrevocable during the Agreement Term or until this Agreement is terminated pursuant to <u>Section 4.1</u>, shall be deemed to be coupled with an interest sufficient in Law to support an irrevocable proxy and shall revoke any and all prior proxies granted by any Stockholder with regard to such Stockholder's Owned Shares and each Stockholder acknowledges that the Proxy constitutes an inducement for Axiom and Circle8 to enter into the Acquisition Agreement and consummate the transactions contemplated thereby. The power of attorney granted by each Stockholder is a durable power of attorney and shall survive the bankruptcy, dissolution, death or incapacity of such Stockholder.

**ARTICLE II<br> REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS**

Each Stockholder, on behalf of itself, severally, but not jointly, hereby represents and warrants to Axiom and Circle8 as of the Effective Date:

**Section 2.1 Power; Due Authorization; Binding Agreement**

Such Stockholder has all requisite corporate power, authority and legal capacity (as applicable) to enter into this Agreement and, subject to receipt of the Requisite Approval, to consummate the transactions contemplated by the Acquisition Agreement, including the Conversion. The execution and delivery of this Agreement and the consummation by such Stockholder of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate, partnership or other applicable action on the part of such Stockholder, and no other proceedings on the part of such Stockholder are necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by such Stockholder and, assuming the due and valid authorization, execution and delivery hereof by the other Parties, constitutes a valid and binding agreement of such Stockholder, enforceable against such Stockholder in accordance with its terms, except that such enforcement may be subject to the Bankruptcy and Equity Exceptions.

**Section 2.2 Ownership of Shares**

Such Stockholder's Owned Shares are owned beneficially and of record by such Stockholder free and clear of any Liens. Such Stockholder does not beneficially own any capital stock or other securities of the Company other than the Owned Shares and does not beneficially own any rights to purchase or acquire any shares of capital stock of the Company except as set forth opposite such Stockholder's name on <u>Exhibit A</u>. Other than restrictions in favor of Axiom pursuant to this Agreement and except for such transfer restrictions of general applicability as may be provided under the Securities Act, as of the Effective Date such Stockholder has (except as otherwise permitted by this Agreement) sole voting power and sole dispositive power with respect to the matters set forth in <u>Section 1.1</u> in respect of all of the Owned Shares of such Stockholder and no proxies have been given in respect of any or all of such Owned Shares other than proxies which have been validly revoked prior to the Effective Date.

**Section 2.3 Adequate Information**

Such Stockholder is a sophisticated holder with respect to the Owned Shares and has adequate information concerning the transactions contemplated by the Acquisition Agreement, including the Conversion, and concerning the business and financial condition of Axiom, Circle8 and the Company to make an informed decision regarding the matters referred to herein and has independently, without reliance upon the Company, Axiom or Circle8, and based on such information as such Stockholder has deemed appropriate, made such Stockholder's own analysis and decision to enter into this Agreement.

**Section 2.4 No Conflict**

The execution and delivery of this Agreement by such Stockholder does not, and the performance of the terms of this Agreement by such Stockholder will not, (a) require the consent or approval of, or any filing with, any other Person, (b) conflict with or violate any organizational document of such Stockholder, (c) conflict with or violate or result in any breach of, or default (with or without notice or lapse of time, or both) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of any Liens on, any of the Owned Shares pursuant to any Contract to which such Stockholder is a party or by which such Stockholder or any of the Owned Shares are bound, or (d) violate any applicable Laws applicable to such Stockholder or any of its assets (including the Owned Shares), except for any of the foregoing which would not, individually or in the aggregate, prevent, materially delay or impair in any material respect the Stockholder's ability to perform its obligations under this Agreement.

**Section 2.5 Acknowledgment**

Such Stockholder understands and acknowledges that Axiom and Circle8 are entering into the Acquisition Agreement in reliance upon such Stockholder's execution, delivery and performance of this Agreement.

**Section 2.6 Transaction Fee**

Such Stockholder has not employed any investment banker, broker or finder in connection with the Contemplated Transactions who is entitled to any fee or any commission from Axiom, Circle8 or the Company or any of their respective Subsidiaries in connection with or upon consummation of the Conversion or any other transaction contemplated by the Acquisition Agreement.

**Section 2.7 Actions and Proceedings**

There are no (a) Actions pending or, to the knowledge of such Stockholder, threatened against such Stockholder or any of its assets or (b) outstanding Orders or Contracts settling any actual or threatened Action to which such Stockholder or any of its assets are subject or bound, in each case, which would prevent, materially delay or impair in any material respect such Stockholder's ability to perform its obligations under this Agreement.

**ARTICLE III<br> COVENANTS OF THE STOCKHOLDERS**

**Section 3.1 Restriction on Transfer, Proxies and Non-Interference**

Each Stockholder hereby agrees, during the Agreement Term, not to, directly or indirectly, voluntarily or involuntarily, (a) sell, transfer, pledge, encumber, assign or otherwise dispose of (including by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange offer, by testamentary disposition, by operation of Law or otherwise), or enter into any Contract, option or other arrangement or understanding with respect to the sale, transfer, pledge, encumbrance, assignment or other disposition of (including by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange offer, by testamentary disposition, by operation of Law or otherwise), or limitation on the voting rights of, any of the Owned Shares or any economic interest therein (any such action, a "<u>Transfer</u>"), (b) grant any proxies or powers of attorney with respect to the Owned Shares of such Stockholder, deposit any such Owned Shares into a voting trust or enter into a voting agreement with respect to any such Owned Shares, in each case with respect to any vote on the approval of the Conversion or any other matters set forth in <u>Section 1.1</u> of this Agreement, (c) form, join, encourage, influence, advise or in any way participate in any "group" (as such term is defined in Section 13(d)(3) of the Exchange Act) with any Persons with respect to any securities of the Company, or (d) commit or agree to take any of the foregoing actions during the Agreement Term; <u>provided</u>, that, the foregoing notwithstanding, the following Transfers are permitted: (i) Transfers of Owned Shares to any affiliate of such Stockholder who has agreed in writing (the form and substance of which is reasonably acceptable to Axiom) to be bound by the terms of this Agreement; or (ii) Transfers of Owned Shares with Axiom's prior written consent (which may be withheld in Axiom's sole discretion).

**Section 3.2 Additional Securities**

From the Effective Date until the earlier of (a) the termination of this Agreement pursuant to <u>Section 4.1</u> and (b) the meeting of Atlantic stockholders at which the Conversion is approved (the "<u>Company Stockholder Meeting</u>"), in the event any Stockholder becomes the record or beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of (i) any shares of Company Common Stock or any other voting securities of the Company, (ii) any securities which may be converted into or exchanged for such share or other securities, or (iii) any securities issued in replacement of, or as a dividend or distribution on, or otherwise in respect of, such shares or other securities (collectively, "<u>Additional Securities</u>"), such Additional Securities will be subject to the terms of this Agreement and the covenants applicable to the Owned Shares hereunder shall apply to such Additional Securities as though owned by the Stockholder on the Effective Date.

**Section 3.3 Acquisition Agreement Obligations**

Each Stockholder agrees that it shall not, and shall cause its affiliates (other than passive investors in the Stockholder who are not otherwise affiliates of the Stockholder or involved in advising or managing such Stockholder or any of its affiliates) and each of its and their respective Representatives not to, directly or indirectly through another Person, (a) solicit, initiate, knowingly encourage (including by means of furnishing or disclosing information), knowingly facilitate, discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with respect to an Acquisition Proposal; (b) furnish or disclose any non-public information to any Person (other than to Axiom, Circle8 and the Company) in connection with, or that would reasonably be expected to lead to an Alternative Proposal; (c) enter into any Contract or other arrangement or understanding regarding an Alternative Proposal; (d) prepare or take any steps in connection with a public offering of any Equity Interests of the Company or its Subsidiaries; or (e) otherwise cooperate in any way with, or assist or participate in, or knowingly facilitate or knowingly encourage any effort or attempt by any Person to do or seek any of the foregoing.

**Section 3.4 Further Assurances**

From time to time, at the reasonable request of Axiom or the Company and without further consideration, each Stockholder shall, at the Company's cost and expense, use reasonable best efforts to execute and deliver such additional documents and take all such further action as may be reasonably necessary to comply with such Stockholder's obligations under this Agreement.

**Section 3.5 Notice of Acquisitions**

Each Stockholder (severally and not jointly) agrees to notify Axiom as promptly as reasonably practicable (and in any event within two Business Days after receipt) orally and in writing of the number of any additional Atlantic Common Stock or other securities of the Company of which such Stockholder acquires beneficial ownership on or after the date hereof.

**Section 3.6 General Covenants**

Each Stockholder agrees that such Stockholder shall not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) enter into any Contract with any Person or take any other action that violates or conflicts with or would reasonably be expected to violate or conflict with, or result in or give rise to a violation of or conflict with, such Stockholder's representations, warranties, covenants and obligations under this Agreement; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) take any action that would restrict or otherwise affect such Stockholder's legal power, authority and right to comply with and perform such Stockholder's covenants and obligations under this Agreement.

**ARTICLE IV<br> MISCELLANEOUS**

**Section 4.1 Termination of this Agreement**

This Agreement, and all obligations, terms and conditions contained herein, shall automatically terminate without any further action required by any Party upon the Conversion Date.

**Section 4.2 Effect of Termination**

In the event of termination of this Agreement pursuant to <u>Section 4.1</u>, this Agreement shall become void and of no effect with no liability on the part of any Party; <u>provided</u>, <u>however</u>, no such termination shall relieve any Party from any liability for any breach of this Agreement occurring prior to such termination and the provisions of this <u>ARTICLE IV</u>, shall survive any such termination. Notwithstanding the foregoing, termination of this Agreement shall not prevent any Party from seeking any remedies (at Law or in equity) against any other Party for that Party's breach of any of the terms of this Agreement prior to the date of termination. Nothing in the Acquisition Agreement shall relieve any Stockholder from any liability arising out of or in connection with this Agreement.

**Section 4.3 Entire Agreement**

This Agreement (together with the Acquisition Agreement and Convertible Note) and other documents delivered in connection with this Agreement contain the entire understanding of the Parties in respect of their subject matter and supersede all prior agreements and understandings (oral or written) between the Parties with respect to such subject matter, other than the confidentiality agreements entered into between the Parties.

**Section 4.4 Binding Effect; Assignment**

The rights and obligations of this Agreement shall bind and inure to the benefit of the Parties and their respective successors and assigns. Except as expressly provided herein, the rights and obligations of this Agreement may not be assigned by any Party without the prior written consent of the other Parties.

**Section 4.5 Amendment**

This Agreement may only be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by each of the Parties, or in the case of a waiver, by the Party against whom the waiver is to be effective. No failure or delay by Axiom or Circle8 in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. No waiver of any provision of this Agreement shall be effective except by written instrument executed by the Party against whom the waiver is to be effective. No extension of time for performance of any obligations or other acts hereunder or under any other agreement shall be deemed to be an extension of the time for performance of any other obligations or any other acts.

**Section 4.6 Notices**

All notices, demands and other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given (a) when personally delivered, (b) one Business Day after deposit with Federal Express or similar overnight courier service for delivery the next Business Day, (c) upon confirmation by email transmission (with a copy sent by overnight prepared courier service for delivery the next Business Day) or (d) three Business Days after being mailed by first class mail, return receipt requested. Notices, demands and other communications to the Parties shall, unless another address is specified in writing, be sent to the addresses indicated below:

if to Axiom or Circle8, to:

Axiom Partners GmbH<br> Gubelstrasse 11<br> Zug Swiss<br> Attention: Guus Franke

Email: [\*\*\*]

with a copy (which shall not constitute notice) to:

Jones Day

250 Vesey Street

New York, NY 10281<br> Attention: Mike Jansen; Ann Bomberger; Rory Hood

Email: mjansen@jonesday.com; ambomberger@jonesday.com; rhood@jonesday.com

if to Atlantic:

Atlantic International Corp.<br> 270 Sylvan Avenue, Suite 2230<br> Englewood Cliffs, NJ 07632<br> Attention: Jeffrey Jagid, Chief Executive Officer<br> Email: jjagid@atlantic-international.com

with a copy (which shall not constitute notice) to:

Davidoff Hutcher & Citron LLP<br> 605 Third Avenue, 34<sup>th</sup> Floor<br> New York, New York 10158<br> Attention: Elliot H. Lutzker, Esq.<br> Email: ehl@dhclegal.com

if to the Stockholders, the address reflected after the applicable signature block for the respective Stockholder.

**Section 4.7 Governing Law**

This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of Delaware.

**Section 4.8 Consent to Jurisdiction**

Each Party hereby submits to the exclusive jurisdiction of the Delaware Court of Chancery or, if under applicable Law the Delaware Court of Chancery does not have proper subject matter jurisdiction, any federal or state court in the State of Delaware (and appellate courts thereof) (the "<u>Delaware Courts</u>") for any dispute arising out of or relating to this Agreement or the breach, termination or validity thereof. Each Party hereby irrevocably and unconditionally waives, to the fullest extent permitted by Law, any objection that it may now or hereafter have to the laying of the venue of any such proceedings brought in such court. Each of the Parties irrevocably and unconditionally waives and agrees not to plead or claim in any such court (a) that it is not personally subject to the jurisdiction of the Delaware Courts for any reason other than the failure to serve process in accordance with applicable Law, (b) that it or its property is exempt or immune from jurisdiction of the Delaware Courts or from any legal process commenced in the Delaware Courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) to the fullest extent permitted by applicable Law that (i) the suit, action or proceeding in the Delaware Courts is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper and (iii) this Agreement, or the subject matter hereof, may not be enforced in or by the Delaware Courts.

**Section 4.9 Waiver of Jury Trial**

EACH PARTY TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

**Section 4.10 Specific Performance**

The Parties agree that irreparable harm would occur if any of the provisions of this Agreement were not performed in accordance with their specific terms on a timely basis or were otherwise breached. It is accordingly agreed that, without posting bond or other undertaking, the Parties shall be entitled to injunctive or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court of competent jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity. In the event that any such action is brought in equity to enforce the provisions of this Agreement, no Party will allege, and each Party hereby waives the defense or counterclaim, that there is an adequate remedy at law. The Parties further agree that (a) by seeking any remedy provided for in this ‎Section <u>4.10</u>, a Party shall not in any respect waive its right to seek any other form of relief that may be available to such Party under this Agreement and (b) nothing contained in this ‎Section <u>4.10</u> shall require any Party to institute any action for (or limit such Party's right to institute any action for) specific performance under this ‎‎Section <u>4.10</u> before exercising any other right under this Agreement.

**Section 4.11 Severability**

If any provisions of this Agreement, or the application thereof to any Person or circumstance, is invalid or unenforceable in any jurisdiction, then (a) a substitute and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable in such jurisdiction, the intent and purpose of the invalid or unenforceable provision, and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability of such provision affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction.

**Section 4.12 Counterparts**

This Agreement may be executed in any number of counterparts (including by means of facsimile and electronically transmitted portable document format (pdf) signature pages), each of which shall be an original but all of which together shall constitute one and the same instrument.

**Section 4.13 Interpretation**

The words "hereof," "herein" and "hereunder" and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. When a reference is made in this Agreement to an Article, Section, paragraph, clause or Exhibit, such reference shall be deemed to be to this Agreement unless otherwise indicated. All Exhibits annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit but not otherwise defined therein shall have the meaning as defined in this Agreement. Whenever the words "include," "includes" or "including" are used in this Agreement, they shall be deemed to be followed by the words "without limitation." References to any "statute" or "regulation" are to the statute or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of statutes, include any rules and regulations promulgated under the statute) and to any "section of any statute or regulation" include any successor to the section. The definition of any singular term in this Agreement will be deemed to include the plural, and any plural term the singular. All pronouns and variations of pronouns will be deemed to refer to the feminine, masculine or neuter, singular or plural, as the identity of the Person referred to may require. Where a word or phrase is defined herein, each of its other grammatical forms shall have a corresponding meaning. All references to "$" in this Agreement shall be deemed references to United States dollars. Unless otherwise indicated, the word "day" shall be interpreted as a calendar day. The headings contained herein (including in the Exhibits) are for reference purposes only and shall not affect in any way the meaning or interpretation hereof. The Parties agree that the terms and language of this Agreement were the result of negotiations between the Parties and their respective advisors and, as a result, there shall be no presumption that any ambiguities in this Agreement shall be resolved against any Party. Any controversy over construction of this Agreement shall be decided without regard to events of authorship or negotiation.

**Section 4.14 Publication**

Each Stockholder hereby permits Company to publish and disclose in any documents or schedules filed with the SEC and any other disclosures or filings required by applicable Law such Stockholder's identity and ownership of the Owned Shares and the nature of such Stockholder's commitments pursuant to this Agreement.

<u>**[*SIGNATURE PAGE FOLLOWS*]**</u>

IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the Effective Date.

---

| |
|:---|
| **Axiom Partners GmbH** |
| By: |
| Name: |
| Title: |
| **ATLANTIC INTERNATIONAL CORP** |
| By: |
| Name: |
| Title: |

---

[Signature Page to Voting and Support Agreement]

---

| |
|:---|
| **STOCKHOLDERS**: |
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |
| Attention: |
| Email: |
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |
| Attention: |
| Email: |

---

[Signature Page to Voting and Support Agreement]

---

| |
|:---|
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |

---

---

| | |
|:---|:---|
| Attention: | [●] |
| Email: | [●] |
| **[●]** | **[●]** |
| By: |  |
| Notice Address: | Notice Address: |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| Attention: | [●] |
| Email: | [●] |
| **[●]** | **[●]** |
| By: |  |
| Notice Address: | Notice Address: |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| Attention: | [●] |
| Email: | [●] |

---

[Signature Page to Voting and Support Agreement]

---

| |
|:---|
| **[●]** |
| By: |
| Notice Address: |
| [●] |

---

---

| |
|:---|
| [●] |
| [●] |
| Attention: |
| Email: |
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |
| Attention: |
| Email: [●] |
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |
| Attention: |
| Email: |
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |
| Attention: |
| Email: |

---

[Signature Page to Voting and Support Agreement]

**<u>Exhibit A</u>**

**<u> </u>**

**Company Stock Ownership**

---

| | |
|:---|:---|
| Stockholder | Number of Shares Beneficially Owned |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |
| [●] | [●] |

---

## Exhibit 99.5

**Exhibit 99.5**

**VOTING AND SUPPORT AGREEMENT**

This VOTING AND SUPPORT AGREEMENT (this "<u>Agreement</u>"), is dated as of January [·], 2026 (the "<u>Effective Date</u>"), is made by and among Axiom Partners GmbH, a company organized under the laws of the Swiss Republic ("<u>Axiom</u>"), Atlantic International Corp., a Delaware corporation ("<u>Company</u>"), and each of the stockholders of the Company as set forth on <u>Exhibit A</u> attached hereto (collectively, the "<u>Stockholders</u>," and individually a "<u>Stockholder</u>"). Axiom, Company and the Stockholders are referred to herein individually as a "<u>Party</u>" and collectively as the "<u>Parties</u>." Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Acquisition Agreement (as defined below).

**RECITALS**

WHEREAS, Axiom, Atlantic and Circle8 Group B.V., a company organized under the laws of the Netherlands ("<u>Circle8</u>"), entered into the Acquisition Agreement, dated as of January [●], 2026 (the "<u>Acquisition Agreement</u>"), pursuant to which, among other things and subject to the terms and conditions of the Acquisition Agreement, Company acquired Circle8 (the "<u>Acquisition</u>") in exchange for the issuance at Closing of shares representing 19.99% of the issued and outstanding common stock of Atlantic and the Convertible Note;

WHEREAS, the board of directors of Atlantic (the "<u>Atlantic Board</u>") has (a) determined that the Acquisition Agreement and all ancillary documents to which Atlantic is or will be a party and the transactions contemplated thereby, including the Acquisition and the Conversion, are fair to and in the best interests of Atlantic and its stockholders, (b) approved, adopted and declared advisable the Acquisition Agreement and the transactions contemplated thereby, including the Acquisition, in accordance with the requirements of the DGCL and (c) resolved to recommend approval of (i) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (ii) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that the Convertible Promissory Note issued to IDC Technologies, Inc. (as assigned) (the "<u>IDC Note</u>") converts, and (iii) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto (such approval, the "<u>Requisite Approval</u>");

WHEREAS, certain stockholders of the Company entered into a Voting and Support Agreement with Axiom and Company concurrently with the execution and delivery of the Acquisition Agreement;

WHEREAS, as a condition to the consummation of the transactions contemplated by the Acquisition Agreement, the Stockholders are entering into this Agreement with Axiom and Company, pursuant to which, among other things, each such Stockholder has agreed to vote as set forth herein; and

WHEREAS, as of the Effective Date, each Stockholder is the record and beneficial owner of the number of shares of Company Common Stock set forth opposite such Stockholder's name on <u>Exhibit A</u> attached hereto (each, including any such Additional Securities (as defined below) an "<u>Owned Share</u>").

NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

**ARTICLE I<br> STOCKHOLDERS CONSENT;<br> AGREEMENT TO VOTE AND IRREVOCABLE PROXY**

**Section 1.1 Agreement to Vote**

Each Stockholder hereby irrevocably and unconditionally agrees that, from the Effective Date until the earlier of (a) the time that the Requisite Approval has been obtained and (b) termination of this Agreement in accordance with <u>Section 4.1</u> (the "<u>Agreement Term</u>"), such Stockholder shall (i) take all such actions as may be reasonably required to cause each of such Stockholder's Owned Shares to be present, in person or by proxy, at the Company Stockholder Meeting and (ii) at any Company Stockholder Meeting vote (or cause to be voted), to the extent entitled to vote thereon, all of such Stockholder's Owned Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) in favor of (I) approval of (1) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (2) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that IDC Note converts, and (3) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto, and (II) the approval of any proposal to adjourn such Company Stockholder Meeting to a later date if there are not sufficient votes for approval of (1) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (2) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that IDC Note converts, and (3) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) against (I) any Alternative Proposal, (II) any action that would reasonably be expected to result in a breach of or failure to perform any representation, warranty, covenant or agreement of the Company under the Acquisition Agreement or the Convertible Note or of such Stockholder under this Agreement, (III) any action that would reasonably be expected to prevent or materially delay or impede the consummation of the transactions contemplated by the Acquisition Agreement, including the Conversion and the issuance of any Contingent Share Consideration, (IV) any merger agreement or merger (other than the Acquisition Agreement and the Conversion), consolidation, combination, material business transaction, sale of assets, reorganization, recapitalization, dissolution, liquidation or winding up of the Company or any of its Subsidiaries, and (V) any amendment of the Company's organizational documents that would reasonably be expected to impair the ability of the Company, Axiom or Circle8 to complete the Contemplated Transactions (including the Conversion and the issuance of any contingent Share Consideration), or that would or would reasonably be expected to prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the consummation of the Conversion or the issuance of the Contingent Share Consideration.

**Section 1.2 Other Voting Rights**

For the avoidance of doubt, except as expressly set forth in this Agreement, nothing in this Agreement shall limit the right of any Stockholder to vote in favor of, against, or abstain with respect to any matter presented to the Company's stockholders not addressed by this Agreement.

**Section 1.3 Grant of Irrevocable Proxy**

Each Stockholder hereby irrevocably appoints Company and any designee of Company, and each of them individually, as such Stockholder's proxy and attorney-in-fact, with full power of substitution and resubstitution, to vote at the Company Stockholder Meeting during the Agreement Term, with respect to such Stockholder's Owned Shares as of the applicable record date, in each case solely to the extent and in the manner specified in <u>Section 1.1</u> (the "<u>Proxy</u>"); <u>provided</u>, <u>however</u>, that such Proxy shall be effective if, and only if, the Stockholder has not delivered to the Corporate Secretary of the Company, at least two Business Days prior to the Company Stockholder Meeting, a duly executed proxy card directing that such Stockholder's Owned Shares be voted in accordance with <u>Section 1.1</u>. The Proxy is given to secure the performance of the duties of each Stockholder under this Agreement, and its existence will not be deemed to relieve any Stockholder of such Stockholder's obligations under this Agreement. The Proxy shall expire and be deemed revoked automatically at the expiration of the Agreement Term or in the event of termination of this Agreement pursuant to <u>Section 4.1</u>.

**Section 1.4 Nature of Irrevocable Proxy**

The Proxy granted by each Stockholder is irrevocable during the Agreement Term or until this Agreement is terminated pursuant to <u>Section 4.1</u>, shall be deemed to be coupled with an interest sufficient in Law to support an irrevocable proxy and shall revoke any and all prior proxies granted by any Stockholder with regard to such Stockholder's Owned Shares and each Stockholder acknowledges that the Proxy constitutes an inducement for Axiom and Circle8 to enter into the Acquisition Agreement and consummate the transactions contemplated thereby. The power of attorney granted by each Stockholder is a durable power of attorney and shall survive the bankruptcy, dissolution, death or incapacity of such Stockholder.

**ARTICLE II<br> REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS**

Each Stockholder, on behalf of itself, severally, but not jointly, hereby represents and warrants to Axiom and Circle8 as of the Effective Date:

**Section 2.1 Power; Due Authorization; Binding Agreement**

Such Stockholder has all requisite corporate power, authority and legal capacity (as applicable) to enter into this Agreement and, subject to receipt of the Requisite Approval, to consummate the transactions contemplated by the Acquisition Agreement, including the Conversion. The execution and delivery of this Agreement and the consummation by such Stockholder of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate, partnership or other applicable action on the part of such Stockholder, and no other proceedings on the part of such Stockholder are necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by such Stockholder and, assuming the due and valid authorization, execution and delivery hereof by the other Parties, constitutes a valid and binding agreement of such Stockholder, enforceable against such Stockholder in accordance with its terms, except that such enforcement may be subject to the Bankruptcy and Equity Exceptions.

**Section 2.2 Ownership of Shares**

Such Stockholder's Owned Shares are owned beneficially and of record by such Stockholder free and clear of any Liens. Such Stockholder does not beneficially own any capital stock or other securities of the Company other than the Owned Shares and does not beneficially own any rights to purchase or acquire any shares of capital stock of the Company except as set forth opposite such Stockholder's name on <u>Exhibit A</u>. Other than restrictions in favor of Axiom pursuant to this Agreement and except for such transfer restrictions of general applicability as may be provided under the Securities Act, as of the Effective Date such Stockholder has (except as otherwise permitted by this Agreement) sole voting power and sole dispositive power with respect to the matters set forth in <u>Section 1.1</u> in respect of all of the Owned Shares of such Stockholder and no proxies have been given in respect of any or all of such Owned Shares other than proxies which have been validly revoked prior to the Effective Date.

**Section 2.3 Adequate Information**

Such Stockholder is a sophisticated holder with respect to the Owned Shares and has adequate information concerning the transactions contemplated by the Acquisition Agreement, including the Conversion, and concerning the business and financial condition of Axiom, Circle8 and the Company to make an informed decision regarding the matters referred to herein and has independently, without reliance upon the Company, Axiom or Circle8, and based on such information as such Stockholder has deemed appropriate, made such Stockholder's own analysis and decision to enter into this Agreement.

**Section 2.4 No Conflict**

The execution and delivery of this Agreement by such Stockholder does not, and the performance of the terms of this Agreement by such Stockholder will not, (a) require the consent or approval of, or any filing with, any other Person, (b) conflict with or violate any organizational document of such Stockholder, (c) conflict with or violate or result in any breach of, or default (with or without notice or lapse of time, or both) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of any Liens on, any of the Owned Shares pursuant to any Contract to which such Stockholder is a party or by which such Stockholder or any of the Owned Shares are bound, or (d) violate any applicable Laws applicable to such Stockholder or any of its assets (including the Owned Shares), except for any of the foregoing which would not, individually or in the aggregate, prevent, materially delay or impair in any material respect the Stockholder's ability to perform its obligations under this Agreement.

**Section 2.5 Acknowledgment**

Such Stockholder understands and acknowledges that Axiom and Circle8 are entering into the Acquisition Agreement in reliance upon such Stockholder's execution, delivery and performance of this Agreement.

**Section 2.6 Transaction Fee**

Such Stockholder has not employed any investment banker, broker or finder in connection with the Contemplated Transactions who is entitled to any fee or any commission from Axiom, Circle8 or the Company or any of their respective Subsidiaries in connection with or upon consummation of the Conversion or any other transaction contemplated by the Acquisition Agreement.

**Section 2.7 Actions and Proceedings**

There are no (a) Actions pending or, to the knowledge of such Stockholder, threatened against such Stockholder or any of its assets or (b) outstanding Orders or Contracts settling any actual or threatened Action to which such Stockholder or any of its assets are subject or bound, in each case, which would prevent, materially delay or impair in any material respect such Stockholder's ability to perform its obligations under this Agreement.

**ARTICLE III<br> COVENANTS OF THE STOCKHOLDERS**

**Section 3.1 Restriction on Transfer, Proxies and Non-Interference**

Each Stockholder hereby agrees, during the Agreement Term, not to, directly or indirectly, voluntarily or involuntarily, (a) sell, transfer, pledge, encumber, assign or otherwise dispose of (including by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange offer, by testamentary disposition, by operation of Law or otherwise), or enter into any Contract, option or other arrangement or understanding with respect to the sale, transfer, pledge, encumbrance, assignment or other disposition of (including by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange offer, by testamentary disposition, by operation of Law or otherwise), or limitation on the voting rights of, any of the Owned Shares or any economic interest therein (any such action, a "<u>Transfer</u>"), (b) grant any proxies or powers of attorney with respect to the Owned Shares of such Stockholder, deposit any such Owned Shares into a voting trust or enter into a voting agreement with respect to any such Owned Shares, in each case with respect to any vote on the approval of the Conversion or any other matters set forth in <u>Section 1.1</u> of this Agreement, (c) form, join, encourage, influence, advise or in any way participate in any "group" (as such term is defined in Section 13(d)(3) of the Exchange Act) with any Persons with respect to any securities of the Company, or (d) commit or agree to take any of the foregoing actions during the Agreement Term; <u>provided</u>, that, the foregoing notwithstanding, the following Transfers are permitted: (i) Transfers of Owned Shares to any affiliate of such Stockholder who has agreed in writing (the form and substance of which is reasonably acceptable to Axiom) to be bound by the terms of this Agreement; or (ii) Transfers of Owned Shares with Axiom's prior written consent (which may be withheld in Axiom's sole discretion).

**Section 3.2 Additional Securities**

From the Effective Date until the earlier of (a) the termination of this Agreement pursuant to <u>Section 4.1</u> and (b) the meeting of Atlantic stockholders at which the Conversion is approved (the "<u>Company Stockholder Meeting</u>"), in the event any Stockholder becomes the record or beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of (i) any shares of Company Common Stock or any other voting securities of the Company, (ii) any securities which may be converted into or exchanged for such share or other securities, or (iii) any securities issued in replacement of, or as a dividend or distribution on, or otherwise in respect of, such shares or other securities (collectively, "<u>Additional Securities</u>"), such Additional Securities will be subject to the terms of this Agreement and the covenants applicable to the Owned Shares hereunder shall apply to such Additional Securities as though owned by the Stockholder on the Effective Date.

**Section 3.3 Acquisition Agreement Obligations**

Each Stockholder agrees that it shall not, and shall cause its affiliates (other than passive investors in the Stockholder who are not otherwise affiliates of the Stockholder or involved in advising or managing such Stockholder or any of its affiliates) and each of its and their respective Representatives not to, directly or indirectly through another Person, (a) solicit, initiate, knowingly encourage (including by means of furnishing or disclosing information), knowingly facilitate, discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with respect to an Acquisition Proposal; (b) furnish or disclose any non-public information to any Person (other than to Axiom, Circle8 and the Company) in connection with, or that would reasonably be expected to lead to an Alternative Proposal; (c) enter into any Contract or other arrangement or understanding regarding an Alternative Proposal; (d) prepare or take any steps in connection with a public offering of any Equity Interests of the Company or its Subsidiaries; or (e) otherwise cooperate in any way with, or assist or participate in, or knowingly facilitate or knowingly encourage any effort or attempt by any Person to do or seek any of the foregoing.

**Section 3.4 Further Assurances**

From time to time, at the reasonable request of Axiom or the Company and without further consideration, each Stockholder shall, at the Company's cost and expense, use reasonable best efforts to execute and deliver such additional documents and take all such further action as may be reasonably necessary to comply with such Stockholder's obligations under this Agreement.

**Section 3.5 Notice of Acquisitions**

Each Stockholder (severally and not jointly) agrees to notify Axiom as promptly as reasonably practicable (and in any event within two Business Days after receipt) orally and in writing of the number of any additional Atlantic Common Stock or other securities of the Company of which such Stockholder acquires beneficial ownership on or after the date hereof.

**Section 3.6 General Covenants**

Each Stockholder agrees that such Stockholder shall not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) enter into any Contract with any Person or take any other action that violates or conflicts with or would reasonably be expected to violate or conflict with, or result in or give rise to a violation of or conflict with, such Stockholder's representations, warranties, covenants and obligations under this Agreement; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) take any action that would restrict or otherwise affect such Stockholder's legal power, authority and right to comply with and perform such Stockholder's covenants and obligations under this Agreement.

**ARTICLE IV<br> MISCELLANEOUS**

**Section 4.1 Termination of this Agreement**

This Agreement, and all obligations, terms and conditions contained herein, shall automatically terminate without any further action required by any Party upon the Conversion Date.

**Section 4.2 Effect of Termination**

In the event of termination of this Agreement pursuant to <u>Section 4.1</u>, this Agreement shall become void and of no effect with no liability on the part of any Party; <u>provided</u>, <u>however</u>, no such termination shall relieve any Party from any liability for any breach of this Agreement occurring prior to such termination and the provisions of this <u>ARTICLE IV</u>, shall survive any such termination. Notwithstanding the foregoing, termination of this Agreement shall not prevent any Party from seeking any remedies (at Law or in equity) against any other Party for that Party's breach of any of the terms of this Agreement prior to the date of termination. Nothing in the Acquisition Agreement shall relieve any Stockholder from any liability arising out of or in connection with this Agreement.

**Section 4.3 Entire Agreement**

This Agreement (together with the Acquisition Agreement and Convertible Note) and other documents delivered in connection with this Agreement contain the entire understanding of the Parties in respect of their subject matter and supersede all prior agreements and understandings (oral or written) between the Parties with respect to such subject matter, other than the confidentiality agreements entered into between the Parties.

**Section 4.4 Binding Effect; Assignment**

The rights and obligations of this Agreement shall bind and inure to the benefit of the Parties and their respective successors and assigns. Except as expressly provided herein, the rights and obligations of this Agreement may not be assigned by any Party without the prior written consent of the other Parties.

**Section 4.5 Amendment**

This Agreement may only be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by each of the Parties, or in the case of a waiver, by the Party against whom the waiver is to be effective. No failure or delay by Axiom or Circle8 in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. No waiver of any provision of this Agreement shall be effective except by written instrument executed by the Party against whom the waiver is to be effective. No extension of time for performance of any obligations or other acts hereunder or under any other agreement shall be deemed to be an extension of the time for performance of any other obligations or any other acts.

**Section 4.6 Notices**

All notices, demands and other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given (a) when personally delivered, (b) one Business Day after deposit with Federal Express or similar overnight courier service for delivery the next Business Day, (c) upon confirmation by email transmission (with a copy sent by overnight prepared courier service for delivery the next Business Day) or (d) three Business Days after being mailed by first class mail, return receipt requested. Notices, demands and other communications to the Parties shall, unless another address is specified in writing, be sent to the addresses indicated below:

if to Axiom or Circle8, to:

Axiom Partners GmbH<br> Gubelstrasse 11<br> Zug Swiss<br> Attention: Guus Franke

Email: [\*\*\*]

with a copy (which shall not constitute notice) to:

Jones Day

250 Vesey Street

New York, NY 10281<br> Attention: Mike Jansen; Ann Bomberger; Rory Hood

Email: mjansen@jonesday.com; ambomberger@jonesday.com; rhood@jonesday.com

if to Atlantic:

Atlantic International Corp.<br> 270 Sylvan Avenue, Suite 2230<br> Englewood Cliffs, NJ 07632<br> Attention: Jeffrey Jagid, Chief Executive Officer<br> Email: jjagid@atlantic-international.com

with a copy (which shall not constitute notice) to:

Davidoff Hutcher & Citron LLP<br> 605 Third Avenue, 34<sup>th</sup> Floor<br> New York, New York 10158<br> Attention: Elliot H. Lutzker, Esq.<br> Email: ehl@dhclegal.com

if to the Stockholders, to the address reflected after the applicable signature block for the respective Stockholder.

**Section 4.7 Governing Law**

This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of Delaware.

**Section 4.8 Consent to Jurisdiction**

Each Party hereby submits to the exclusive jurisdiction of the Delaware Court of Chancery or, if under applicable Law the Delaware Court of Chancery does not have proper subject matter jurisdiction, any federal or state court in the State of Delaware (and appellate courts thereof) (the "<u>Delaware Courts</u>") for any dispute arising out of or relating to this Agreement or the breach, termination or validity thereof. Each Party hereby irrevocably and unconditionally waives, to the fullest extent permitted by Law, any objection that it may now or hereafter have to the laying of the venue of any such proceedings brought in such court. Each of the Parties irrevocably and unconditionally waives and agrees not to plead or claim in any such court (a) that it is not personally subject to the jurisdiction of the Delaware Courts for any reason other than the failure to serve process in accordance with applicable Law, (b) that it or its property is exempt or immune from jurisdiction of the Delaware Courts or from any legal process commenced in the Delaware Courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) to the fullest extent permitted by applicable Law that (i) the suit, action or proceeding in the Delaware Courts is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper and (iii) this Agreement, or the subject matter hereof, may not be enforced in or by the Delaware Courts.

**Section 4.9 Waiver of Jury Trial**

EACH PARTY TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

**Section 4.10 Specific Performance**

The Parties agree that irreparable harm would occur if any of the provisions of this Agreement were not performed in accordance with their specific terms on a timely basis or were otherwise breached. It is accordingly agreed that, without posting bond or other undertaking, the Parties shall be entitled to injunctive or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court of competent jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity. In the event that any such action is brought in equity to enforce the provisions of this Agreement, no Party will allege, and each Party hereby waives the defense or counterclaim, that there is an adequate remedy at law. The Parties further agree that (a) by seeking any remedy provided for in this ‎Section <u>4.10</u>, a Party shall not in any respect waive its right to seek any other form of relief that may be available to such Party under this Agreement and (b) nothing contained in this ‎Section <u>4.10</u> shall require any Party to institute any action for (or limit such Party's right to institute any action for) specific performance under this ‎‎Section <u>4.10</u> before exercising any other right under this Agreement.

**Section 4.11 Severability**

If any provisions of this Agreement, or the application thereof to any Person or circumstance, is invalid or unenforceable in any jurisdiction, then (a) a substitute and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable in such jurisdiction, the intent and purpose of the invalid or unenforceable provision, and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability of such provision affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction.

**Section 4.12 Counterparts**

This Agreement may be executed in any number of counterparts (including by means of facsimile and electronically transmitted portable document format (pdf) signature pages), each of which shall be an original but all of which together shall constitute one and the same instrument.

**Section 4.13 Interpretation**

The words "hereof," "herein" and "hereunder" and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. When a reference is made in this Agreement to an Article, Section, paragraph, clause or Exhibit, such reference shall be deemed to be to this Agreement unless otherwise indicated. All Exhibits annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit but not otherwise defined therein shall have the meaning as defined in this Agreement. Whenever the words "include," "includes" or "including" are used in this Agreement, they shall be deemed to be followed by the words "without limitation." References to any "statute" or "regulation" are to the statute or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of statutes, include any rules and regulations promulgated under the statute) and to any "section of any statute or regulation" include any successor to the section. The definition of any singular term in this Agreement will be deemed to include the plural, and any plural term the singular. All pronouns and variations of pronouns will be deemed to refer to the feminine, masculine or neuter, singular or plural, as the identity of the Person referred to may require. Where a word or phrase is defined herein, each of its other grammatical forms shall have a corresponding meaning. All references to "$" in this Agreement shall be deemed references to United States dollars. Unless otherwise indicated, the word "day" shall be interpreted as a calendar day. The headings contained herein (including in the Exhibits) are for reference purposes only and shall not affect in any way the meaning or interpretation hereof. The Parties agree that the terms and language of this Agreement were the result of negotiations between the Parties and their respective advisors and, as a result, there shall be no presumption that any ambiguities in this Agreement shall be resolved against any Party. Any controversy over construction of this Agreement shall be decided without regard to events of authorship or negotiation.

**Section 4.14 Publication**

Each Stockholder hereby permits Company to publish and disclose in any documents or schedules filed with the SEC and any other disclosures or filings required by applicable Law such Stockholder's identity and ownership of the Owned Shares and the nature of such Stockholder's commitments pursuant to this Agreement.

<u>**[*SIGNATURE PAGE FOLLOWS*]**</u>

IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the Effective Date.

---

| |
|:---|
| **Axiom Partners GmbH** |
| By: |
| Name: |
| Title: |
| **ATLANTIC INTERNATIONAL CORP** |
| By: |
| Name: |
| Title: |

---

[Signature Page to Voting and Support Agreement]

---

| |
|:---|
| **STOCKHOLDERS**: |
| **[●]** |
| By: |
| Notice Address: |
| [●] |
| [●] |
| [●] |
| Attention: |
| Email: |

---

[Signature Page to Voting and Support Agreement]

**<u>Exhibit A</u>**

**Company Stock Ownership**

<u>Stockholder</u> <u>Number of Shares Beneficially Owned</u> <br> [●] [●]

## Exhibit 99.6

**Exhibit 99.6**

**JOINT FILING AGREEMENT**

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree to the joint filing with all other persons signatory below of a statement on Schedule 13D or any amendments thereto, with respect to the shares of Common Stock of Atlantic International Corp., and that this Agreement be included as an attachment to such filing.

This Agreement may be executed in any number of counterparts each of which shall be deemed an original and all of which together shall be deemed to constitute one and the same Agreement.

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement on February 10, 2026.

---

| |
|:---|
| /s/ Guus Paul Wilhelm Franke |
| Guus Paul Wilhelm Franke |
| /s/ Guus Paul Wilhelm Franke |
| Axiom Partners GmbH, by Guus Paul Wilhelm Franke,<br> Chief Executive Officer |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**ATLANTIC INTERNATIONAL CORP.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**048592109**

*(CUSIP Number)*

**Guus Paul Wilhelm Franke**<br>Gubelstrasse 11<br>Zug V8 3600<br>41 (41) 711-4476

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**01/23/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **048592109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Guus Paul Wilhelm Franke** | Name of reporting person<br>**Guus Paul Wilhelm Franke** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**SC** | Source of funds (See Instructions)<br>**SC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**P7** | Citizenship or place of organization<br>**P7** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**12516070.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**12516070.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**12516070.00** | Aggregate amount beneficially owned by each reporting person<br>**12516070.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**16.66%** | Percent of class represented by amount in Row (11)<br>**16.66%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** Row 13: Based on (1) 62,611,656 shares of Common Stock, par value $0.00001 ("Common Stock"), of Atlantic International Corp. (the "Issuer"), outstanding on January 22, 2026, based on information disclosed in Exhibit 2.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on January 28, 2026 and (2) the 12,516,070 shares of Common Stock issued pursuant to the Acquisition Agreement (as defined below).

| **CUSIP No.** | **048592109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Axiom Partners GmbH** | Name of reporting person<br>**Axiom Partners GmbH** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**V8** | Citizenship or place of organization<br>**V8** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**0.00** | Aggregate amount beneficially owned by each reporting person<br>**0.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
ATLANTIC INTERNATIONAL CORP.

**(c) Address of Issuer's Principal Executive Offices:**
270 Sylvan Avenue, Suite 2230, Englewood Cliffs, NJ, 07632

**Item 4. Purpose of Transaction**

The information set forth in or incorporated by reference in Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4.

The Reporting Persons acquired the securities described in this Schedule 13D for investment purposes. The Reporting Persons review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, actions taken by the board of directors (the "Atlantic Board"), price levels of the Common Stock, other investment opportunities available to the Reporting Persons, conditions in the securities markets and general economic and industry conditions ("Evaluation Factors"), the Reporting Persons may from time to time and at any time in the future determine (i) to acquire additional Common Stock and/or other equity, debt, notes or other securities of the Issuer, or derivative or other instruments that are based upon or relate to the value of the Common Stock (collectively, "Securities") in the open market, through private agreements or otherwise; (ii) to dispose of all or a portion of their Securities through public offerings or private transactions; (iii) to engage in any hedging or similar transactions with respect to the Securities; or (iv) to take any other available course of action.

The aggregate consideration for the Acquisition was equal to fifty percent of the shares of Common Stock on a Fully Diluted Basis (as defined in the Acquisition Agreement), which was delivered on January 23, 2026 as follows: (i) a number of shares issued to GF equal to 19.99% of the issued and outstanding shares of Common Stock as of the Closing Date (the "Initial Share Consideration"), and (ii) a convertible loan note issued to Axiom (the "Convertible Note").

The Convertible Note was issued in a principal amount of $161,961,751.20 convertible into an aggregate of 53,291,744 shares of Common Stock, equal to (i) 65,807,814 shares of Common Stock on a Fully Diluted Basis minus (ii) the Initial Share Consideration (the "Convertible Note Consideration"). The maturity date ("Maturity Date") of the Convertible Note shall be the earlier of: (a) twelve months from the date of issuance, (b) the date when the Issuer's stockholders approve the issuance of the Conversion Shares (as defined in the Convertible Note) in an amount equal to the Convertible Note Consideration, or (c) any other date on which any principal amount is declared to be, or becomes, due and payable pursuant to its terms prior to the Maturity Date pursuant to the terms of the Convertible Note.

Furthermore, in the event that the Convertible Promissory Note (the "IDC Promissory Note"), issued on June 18, 2024, as amended, to IDC Technologies, Inc. ("IDC") is converted to shares of Common Stock at the election of the IDC (as assigned), the Issuer shall, subject to receipt of the Required Company Stockholder Approval (as defined in the Acquisition Agreement), issue additional shares of Common Stock to Axiom (or its assignees) such that Axiom receives the same number of shares of Common Stock that it would have been entitled to if the number of shares issued to the IDC pursuant to the IDC Promissory Note had been reflected in the calculation of Common Stock on a Fully Diluted Basis (the "Contingent Share Consideration").

Pursuant to the Acquisition Agreement, the Issuer (i) established the size of the Atlantic Board at six directors, (ii) nominated and appointed, effective as of the Closing, GF to the Atlantic Board and (iii) caused him to serve as Executive Chairman of the Atlantic Board from and after the Closing with all rights and privileges including, but not limited to, the right to call a stockholders meeting. As Executive Chairman of the Atlantic Board, GF entered into an employment and board service agreement with the Issuer (the "Employment and Board Service Agreement"), which provides all executive perks, including stock options that vest over time and other stock incentives for achieving mutually agreed upon revenue or other financial targets.

GF was appointed to the Atlantic Board by Axiom pursuant to Axiom's right to designate a director to serve on the Atlantic Board under the Acquisition Agreement.

The Acquisition Agreement provides for registration rights, subject to certain exceptions. Following Closing, the Issuer must promptly file a registration statement for the Initial Share Consideration. Additionally, after any conversion of the Convertible Note into the Convertible Note Consideration, or upon receipt of the Contingent Share Consideration, the Issuer must promptly file a second registration statement to register such additional shares.

Voting Agreements

Concurrently with the execution of the Acquisition Agreement, Andrew Bressman, Jack Bressman, Christopher Broderick, Jeffrey Jagid, Jonathan Jagid, Joshua Jagid, Robert Machinist, Peri Sason, and Michael Tenore, representing, in the aggregate, 28.71% of the sum of (1) 62,611,656 issued and outstanding shares of Common Stock on January 22, 2026 and (2) the 12,516,070 shares of Common Stock issued pursuant to the Acquisition Agreement, entered into a Voting and Support Agreement with Axiom and the Issuer (the "Pre-Signing Voting Agreement"). Additionally, after the execution of the Acquisition Agreement, Francis Aylward, Allan Hartley, and R. W. Jones, representing, in the aggregate, 14.61% of the sum of (1) 62,611,656 issued and outstanding shares of Common Stock on January 22, 2026 and (2) the 12,516,070 shares of Common Stock issued pursuant to the Acquisition Agreement, each entered into a Post-Signing Voting and Support Agreement with Axiom and the Issuer (the "Post-Signing Voting Agreements" and, together with the Pre-Signing Voting Agreement, the "Voting Agreements").

Pursuant to the Voting Agreements, each of the stockholders agreed, subject to certain exceptions, to vote in favor of (I) approval of (1) the issuance of the shares of Common Stock issuable upon full conversion of the Convertible Note, (2) the additional issuance of shares of Common Stock contemplated to be issued to Axiom (or its designee) under the Acquisition Agreement in the event that the IDC Promissory Note converts, and (3) the transactions contemplated by the Acquisition Agreement and any agreements ancillary thereto, and (II) the approval of any proposal to adjourn the Company Stockholder Meeting (as defined in the Voting Agreements) to a later date if there are not sufficient votes for such approvals.

Additionally, pursuant to the Voting Agreements, each of the stockholders has agreed, subject to certain exceptions, to vote against (1) any Alternative Proposal (as defined in the Voting Agreements), (2) any action that would reasonably be expected to result in a breach of or failure to perform any representation, warranty, covenant or agreement of the Issuer under the Acquisition Agreement or the Convertible Note or of any stockholder under the Voting Agreements, (3) any action that would reasonably be expected to prevent or materially delay or impede the consummation of the transactions contemplated by the Acquisition Agreement, (4) any merger agreement or merger (other than the Acquisition Agreement and the conversion of the Convertible Note), consolidation, combination, material business transaction, sale of assets, reorganization, recapitalization, dissolution, liquidation or winding up of Atlantic or any of its subsidiaries, and (5) any amendment of the Issuer's organizational documents that would reasonably be expected to impair the ability of the Issuer, Axiom or Circle8 to complete the transactions contemplated by the Acquisition Agreement, or that would or would reasonably be expected to prevent, impede, frustrate, interfere with, delay, postpone or adversely affect the consummation of the conversion of the Convertible Note or the issuance of the Contingent Share Consideration.

In addition, pursuant to an agreement dated November 12, 2025, by and between Axiom and E.F. Hutton & Co, LLC ("EF Hutton") concerning financial advisory services provided to Axiom, EF Hutton was paid a transaction fee of 4,000,000 shares of Common Stock. In connection with the Acquisition, GF entered into a proxy agreement with EF Hutton under which EF Hutton granted GF the right to vote its shares of Common Stock in any meeting of stockholders to be called related to the Acquisition.

The foregoing descriptions of the Acquisition Agreement, the Convertible Note, the Employment and Board Service Agreement, and the Voting Agreements do not purport to be complete and are qualified in their entirety by reference to the Acquisition Agreement, the Convertible Note, the Employment and Board Service Agreement, and the forms of each of the Voting Agreements, which are attached as Exhibit 99.1, Exhibit 99.2, Exhibit 99.3, Exhibit 99.4 and Exhibit 99.5, respectively, to this Schedule 13D and are hereby incorporated in their entirety into this Item 4 by reference.

From time to time, the Reporting Persons intend to engage in discussions with the Atlantic Board and/or members of the Issuer's management team concerning a broad range of operational and strategic matters, including, without limitation, the Issuer's business, operations, capital structure, governance (including the need for, and scope of, any special purpose committees of the Atlantic Board), management, and strategy as well as potential financings, business combinations, strategic alternatives, and other matters concerning the Issuer, including transactions and commercial arrangements in which the Reporting Persons may seek to participate and potentially engage. The Reporting Persons intend to communicate with other stockholders or third parties regarding the foregoing, including negotiating with such third parties regarding the terms of potential transactions or other proposals that may be presented to the Reporting Persons.

Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change their intention with respect to any or all of such matters. In reaching any decision as to their course of action (as well as to the specific elements thereof), the Reporting Persons currently intend to take some or all of the Evaluation Factors into consideration.

Except as set forth in this Item 4 of this Schedule 13D, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of the instructions to Item 4 of this Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of January 23, 2026, the aggregate number of shares of Common Stock beneficially owned by GF is 12,516,070 shares of Common Stock (the "Subject Shares"), which equals 16.66% of the sum of (1) 62,611,656 shares of Common Stock outstanding as of January 22, 2026 and (2) the 12,516,070 shares of Common Stock issued pursuant to the Acquisition Agreement. Axiom may be deemed to hold 0 shares, or 0% of the outstanding Common Stock.

**(b)**
GF, as sole managing member and beneficial owner of Axiom, has sole power to vote or direct the vote of (and sole power to dispose or direct the disposition of) the Subject Shares. GF would hold sole voting power and dispositive power over any shares held by Axiom; however, Axiom holds no shares.

Axiom specifically disclaims beneficial ownership of the securities reported herein that it does not directly own.

**(c)**
Except as described in Item 4, the Reporting Persons have not effected any transactions in the Common Stock during the past sixty days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

On February 10, 2026, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer. The Joint Filing Agreement is attached hereto as Exhibit 99.6 and is incorporated herein by reference.

The descriptions of the Acquisition Agreement, the Convertible Note, the Employment and Board Service Agreement and the Voting Agreements set forth in Item 4 are hereby incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Guus Paul Wilhelm Franke

**Signature:** /s/ Guus Paul Wilhelm Franke

**Name/Title:** Guus Paul Wilhelm Franke

**Date:** 02/10/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Axiom Partners GmbH

**Signature:** /s/ Guus Paul Wilhelm Franke

**Name/Title:** Axiom Partners GmbH, by Guus Paul Wilhelm Franke, Chief Executive Officer

**Date:** 02/10/2026